PXD002665 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Quantitative phosphoproteomics analysis of ERBB3/ERBB4 signaling |
| Description | The four members of the epidermal growth factor receptor (EGFR/ERBB) family form homo- and heterodimers which mediate ligand-specific regulation of many key cellular processes in normal and cancer tissues. While signaling through the EGFR has been extensively studied on the molecular level, signal transduction through ERBB3/ERBB4 heterodimers is less well understood. Here, we generated isogenic mouse Ba/F3 cells that express full-length and functional membrane-integrated ERBB3 and ERBB4 or ERBB4 alone, to serve as a defined cellular model for biological and phosphoproteomics analysis of ERBB3/ERBB4 signaling. ERBB3 co-expression significantly enhanced Ba/F3 cell proliferation upon neuregulin-1 (NRG1) treatment. For comprehensive signaling studies we performed quantitative mass spectrometry (MS) experiments to compare the basal ERBB3/ERBB4 cell phosphoproteome to NRG1 treatment of ERBB3/ERBB4 and ERBB4 cells. We employed a workflow comprising differential isotope labeling with mTRAQ reagents followed by chromatographic peptide separation and final phosphopeptide enrichment prior to MS analysis. Overall, we identified 9686 phosphorylation sites which could be confidently localized to specific residues. Statistical analysis of three replicate experiments revealed 492 phosphorylation sites which were significantly changed in NRG1-treated ERBB3/ERBB4 cells. Bioinformatics data analysis recapitulated regulation of mitogen-activated protein kinase and Akt pathways, but also indicated signaling links to cytoskeletal functions and nuclear biology. Comparative assessment of NRG1-stimulated ERBB4 Ba/F3 cells indicated that ERBB3 did not trigger defined signaling pathways but more broadly enhanced phosphoproteome regulation in cells expressing both receptors. In conclusion, our data provide the first global picture of ERBB3/ERBB4 signaling and provide numerous potential starting points for further mechanistic studies |
| HostingRepository | PRIDE |
| AnnounceDate | 2024-10-22 |
| AnnouncementXML | Submission_2024-10-22_03:59:05.798.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Sebastian Wandinger |
| SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
| ModificationList | phosphorylated residue |
| Instrument | LTQ Orbitrap Velos |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2015-08-04 23:46:43 | ID requested | |
| 1 | 2016-01-15 06:37:02 | announced | |
| ⏵ 2 | 2024-10-22 03:59:14 | announced | 2024-10-22: Updated project metadata. |
Publication List
| 10.1371/journal.pone.0146100; |
| Wandinger SK, Lahortiga I, Jacobs K, Klammer M, Jordan N, Elschenbroich S, Parade M, Jacoby E, Linders JT, Brehmer D, Cools J, Daub H, Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. PLoS One, 11(1):e0146100(2016) [pubmed] |
Keyword List
| curator keyword: Biological, Biomedical |
| submitter keyword: ERBB3, ERBB4, phosphoproteomics |
Contact List
| Henrik Daub |
| contact affiliation | Evotec (München) GmbH |
| contact email | henrik.daub@evotec.com |
| lab head | |
| Sebastian Wandinger |
| contact affiliation | Evotec |
| contact email | sebastian.wandinger@evotec.com |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/01/PXD002665 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD002665
- Label: PRIDE project
- Name: Quantitative phosphoproteomics analysis of ERBB3/ERBB4 signaling